Search Results
html
Degrading viral RNA to treat SARS-CoV-2 infection - American Chemical Society
Researchers reporting in ACS Central Science have developed a system that directly targets and degrades the viral RNA genome, reducing infection in mi ...
https://www.acs.org/pressroom/presspacs/2023/april/degrading-viral-rna-to-treat-sars-cov-2-infection.html12.8KB2023-04-26
html
Keeping SARS-CoV-2 closed for business with small molecules - American Chemical Society
Researchers report in ACS Central Science that they have discovered small molecules that successfully target segments on the SARS-CoV-2 virus that mut ...
https://www.acs.org/pressroom/presspacs/2023/february/keeping-sars-cov-2-closed-for-business-with-small-molecules.html12.8KB2023-02-08
html
Targeting a human protein to squash SARS-CoV-2 and other viruses - American Chemical Society
In ACS Infectious Diseases, scientists now report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the ...
https://www.acs.org/pressroom/newsreleases/2022/june/targeting-a-human-protein-to-squash-sars-cov-2-and-other-viruses.html12.5KB2022-06-29
html
SARS-CoV-2 mimics could accelerate vaccine research, make it safer - American Chemical Society
Researchers reporting in ACS Infectious Diseases have developed a new tool and possible vaccine candidate that could help scientists understand how SA ...
https://www.acs.org/pressroom/newsreleases/2022/september/sars-cov-2-mimics-could-accelerate-vaccine-research-make-it-safe.html12.2KB2022-09-21
html
Testing environmental water to monitor COVID-19 spread in unsheltered encampments - American Chemica
Researchers sampled waterways near unsheltered encampments to better assess the spread of COVID-19 in a population particularly vulnerable to severe i ...
https://www.acs.org/pressroom/presspacs/2024/april/testing-environmental-water-to-monitor-covid-19-spread-in-unsheltered-encampments.html13KB2024-04-03
html
Common coronavirus infections don’t generate effective antibodies against SARS-CoV-2 - American
Researchers reporting in ACS Infectious Diseases have shown that infections with two different common human coronaviruses don’t generate antibodies th ...
https://www.acs.org/pressroom/newsreleases/2022/march/common-coronavirus-infections-dont-generate-effective-antibodies.html12.1KB2022-03-30
html
Wearable air sampler assesses personal exposure to SARS-CoV-2 - American Chemical Society
Researchers reporting in ACS’ Environmental Science & Technology Letters have developed a passive air sampler clip that can help assess personal expos ...
https://www.acs.org/pressroom/presspacs/2022/acs-presspac-january-12-2022/wearable-air-sampler-assesses-personal-exposure-to-sars-cov-2.html12.6KB2022-01-12
html
SARS-CoV-2 protein interacts with Parkinson’s protein, promotes amyloid formation - American
Researchers reporting in ACS Chemical Neuroscience have shown the SARS-CoV-2 N-protein interacts with α-synuclein and speeds formation of amyloid fibr ...
https://www.acs.org/pressroom/newsreleases/2021/december/sars-cov-2-protein-interacts-with-parkinsons-protein-promotes-amyloid-formation.html12.2KB2021-12-14
html
A glucose meter could soon say whether you have SARS-CoV-2 antibodies - American Chemical Society
In the Journal of the American Chemical Society, researchers now report a simple, accurate glucose-meter-based test incorporating a novel fusion prote ...
https://www.acs.org/pressroom/newsreleases/2022/june/glucose-meter-could-soon-say-whether-you-have-sars-cov-2-antibodies.html12.3KB2022-06-16
html
Increased infectivity, antibody escape drive SARS-CoV-2 evolution, studies say - American Chemical
Researchers report in ACS Infectious Diseases and the Journal of Chemical Information and Modeling that omicron and other variants are evolving increa ...
https://www.acs.org/pressroom/presspacs/2022/acs-presspac-february-16-2022/increased-infectivity-antibody-escape-drive-sars-cov-2-evolution.html12.6KB2022-02-16